Eagle Rock Investment Company’s Pfizer PFE Stock Holding History

Eagle Rock Investment Company’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.17M	Sell	89,923 -1,983	-2%	-$51.9K	0.27%	69
2026 Q1	$2.58M	Buy	91,906 +1,437	+2%	+$38.3K	0.38%	62
2025 Q4	$2.25M	Sell	90,469 -7,972	-8%	-$201K	0.32%	69
2025 Q3	$2.51M	Sell	98,441 -8,904	-8%	-$220K	0.37%	67
2025 Q2	$2.6M	Sell	107,345 -8,423	-7%	-$196K	0.41%	62
2025 Q1	$2.93M	Sell	115,768 -2,204	-2%	-$57.7K	0.5%	56
2024 Q4	$3.13M	Sell	117,972 -164,375	-58%	-$4.46M	0.52%	55
2024 Q3	$8.17M	Buy	282,347 +40,806	+17%	+$1.19M	1.37%	19
2024 Q2	$6.76M	Buy	241,541 +64,459	+36%	+$1.77M	1.22%	22
2024 Q1	$4.91M	Buy	177,082 +62,999	+55%	+$1.75M	0.91%	33
2023 Q4	$3.28M	Buy	+114,083	New	+$3.45M	0.67%	44

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Eagle Rock Investment Company's PFE Position: Q2 2026 in Review

Eagle Rock Investment Company reduced its Pfizer (PFE) stake by 2.2% in Q2 2026, selling an estimated $51.9K and leaving 89,923 shares worth $2.17M. The position accounts for 0.27% of the portfolio, ranked #69.

Eagle Rock Investment Company first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $8.17M in Q3 2024. 940 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Eagle Rock Investment Company held 89,923 shares of Pfizer worth $2.17M as of Q2 2026.
Eagle Rock Investment Company sold 1,983 Pfizer shares in Q2 2026, an estimated $51.9K.
Pfizer made up 0.27% of Eagle Rock Investment Company's portfolio in Q2 2026, its #69 holding.
Eagle Rock Investment Company first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
Eagle Rock Investment Company's Pfizer position peaked at $8.17M in Q3 2024.
940 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Eagle Rock Investment Company's 13F filing for Q2 2026, filed 9 Jul 2026.